Astrana Health Future Growth
Future criteria checks 5/6
Astrana Health is forecast to grow earnings and revenue by 20.2% and 20.3% per annum respectively while EPS is expected to grow by 18.9% per annum.
Key information
20.2%
Earnings growth rate
18.9%
EPS growth rate
Healthcare earnings growth | 20.9% |
Revenue growth rate | 20.3% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 21 Nov 2024 |
Recent future growth updates
Recent updates
Impressive Earnings May Not Tell The Whole Story For Astrana Health (NASDAQ:ASTH)
Nov 22Astrana Health, Inc.'s (NASDAQ:ASTH) 33% Cheaper Price Remains In Tune With Earnings
Nov 18Here's What Analysts Are Forecasting For Astrana Health, Inc. (NASDAQ:ASTH) After Its Third-Quarter Results
Nov 10Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 25% Share Price Bounce
Oct 04Is Astrana Health, Inc. (NASDAQ:ASTH) Trading At A 21% Discount?
Sep 26Astrana Health's (NASDAQ:ASTH) Returns On Capital Not Reflecting Well On The Business
Sep 12Is Astrana Health (NASDAQ:ASTH) Using Too Much Debt?
Aug 28Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors
Aug 02Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?
Jun 19Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal
Jun 02Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 09Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)
Apr 15At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?
Feb 25Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Feb 07Apollo Medical Holdings: Good Company, Not Quite A Hold
Jan 17With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For
Dec 27Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled
Nov 08Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?
Oct 26Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet
Sep 22Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down
Aug 04A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Jul 19We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt
Jun 19Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher
May 05Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?
Apr 20Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?
Mar 21Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward
Jan 06Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Dec 16Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 3,219 | 96 | N/A | 128 | 7 |
12/31/2025 | 2,600 | 72 | 84 | 108 | 11 |
12/31/2024 | 1,982 | 57 | 56 | 98 | 10 |
9/30/2024 | 1,722 | 62 | 70 | 82 | N/A |
6/30/2024 | 1,592 | 68 | 50 | 64 | N/A |
3/31/2024 | 1,454 | 62 | 52 | 66 | N/A |
12/31/2023 | 1,387 | 61 | 40 | 68 | N/A |
9/30/2023 | 1,328 | 45 | 112 | 134 | N/A |
6/30/2023 | 1,297 | 46 | 61 | 83 | N/A |
3/31/2023 | 1,218 | 45 | 46 | 66 | N/A |
12/31/2022 | 1,144 | 45 | 59 | 82 | N/A |
9/30/2022 | 1,045 | 58 | -40 | -15 | N/A |
6/30/2022 | 955 | 69 | 41 | 72 | N/A |
3/31/2022 | 861 | 70 | 48 | 84 | N/A |
12/31/2021 | 774 | 69 | 51 | 70 | N/A |
9/30/2021 | 756 | 70 | 63 | 80 | N/A |
6/30/2021 | 709 | 53 | 57 | 65 | N/A |
3/31/2021 | 698 | 47 | 64 | 65 | N/A |
12/31/2020 | 687 | 38 | 45 | 46 | N/A |
9/30/2020 | 689 | 35 | 52 | 52 | N/A |
6/30/2020 | 665 | 22 | 47 | 48 | N/A |
3/31/2020 | 630 | 18 | 7 | 8 | N/A |
12/31/2019 | 561 | 14 | 13 | 14 | N/A |
9/30/2019 | 488 | 4 | 3 | 4 | N/A |
6/30/2019 | 499 | 10 | -11 | -10 | N/A |
3/31/2019 | 492 | 9 | 16 | 17 | N/A |
12/31/2018 | 520 | 11 | 24 | 25 | N/A |
9/30/2018 | 506 | 28 | 46 | 47 | N/A |
6/30/2018 | 436 | 24 | N/A | 41 | N/A |
3/31/2018 | 395 | 24 | N/A | 35 | N/A |
12/31/2017 | 356 | 26 | N/A | 52 | N/A |
9/30/2017 | 336 | 13 | N/A | 44 | N/A |
6/30/2017 | 323 | 11 | N/A | 45 | N/A |
3/31/2017 | 317 | 12 | N/A | 47 | N/A |
12/31/2016 | 306 | 11 | N/A | 22 | N/A |
12/31/2015 | 313 | 13 | N/A | 32 | N/A |
12/31/2014 | 134 | -1 | N/A | 16 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ASTH's forecast earnings growth (20.2% per year) is above the savings rate (2.6%).
Earnings vs Market: ASTH's earnings (20.2% per year) are forecast to grow faster than the US market (15.4% per year).
High Growth Earnings: ASTH's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ASTH's revenue (20.3% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: ASTH's revenue (20.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ASTH's Return on Equity is forecast to be high in 3 years time